FULC
Fulcrum Therapeutics Inc
3.70$
-0.5%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 94.1% | 94.0% | 93.7% | 95.3% | 95.9% | 95.9% | 95.8% | 95.9% | 95.8% | 97.6% | 97.7% | 99.7% | |
| 10.8% | 9.9% | 17.2% | 29.5% | 26.0% | 22.3% | 17.4% | 18.6% | 21.9% | 53.9% | 14.5% | 15.0% | |
| 92.2% | 91.7% | 91.7% | 93.0% | 92.2% | 92.4% | 93.4% | 93.6% | 93.4% | 96.2% | 96.1% | 98.4% | |
| 0.6% | 0.9% | 0.5% | 1.2% | 1.3% | 1.3% | 1.0% | 0.6% | 0.4% | 0.3% | 0.5% | 0.6% | |
| -0.4% | – | – | – | – | – | – | – | – | – | – | – | |
| 8.4% | 8.7% | 8.2% | 7.0% | 7.8% | 6.8% | 5.8% | 6.3% | 7.7% | 4.7% | 3.9% | 4.1% | |
| 5.0% | 5.3% | 4.6% | 4.3% | 5.2% | 4.2% | 3.3% | 3.9% | 5.4% | 3.6% | 2.8% | 3.2% | |
| 0.8% | 0.9% | 0.9% | 0.7% | 0.8% | 0.8% | 0.9% | 1.0% | 1.1% | 0.7% | 0.7% | 0.8% | |
| 1.3% | 1.1% | 1.7% | 1.2% | 1.4% | 0.4% | 0.6% | 0.8% | 1.3% | 0.4% | 0.7% | 1.1% | |
| 91.6% | 91.3% | 91.8% | 93.0% | 92.2% | 93.2% | 94.2% | 93.7% | 92.3% | 95.3% | 96.1% | 95.9% | |
| -173.9% | -197.8% | -230.7% | -163.5% | -180.2% | -199.2% | -221.3% | -242.2% | -267.1% | -162.2% | -176.8% | -197.4% | |
| 22.2% | 24.0% | 26.6% | 21.6% | 22.4% | 20.7% | 25.7% | 27.3% | 29.1% | 17.3% | 22.0% | 23.5% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.